The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the second quarter.
Source: MedTech Dive
You may also like
As GOP Cries Fraud, Newsom Backs Medicaid Spending on...
Lawmakers Look To Make Abortion Shield Laws Less...
A Sales Tax on Doctor Visits and Medicine? In...
Readers Share Personal Insights on Deadly Denials and...
Listen to the Latest ‘KFF Health News Minute’
Trump’s CDC Nominee Praises Vaccines, Without Vowing...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.